Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

IDT to host webinar on high throughput qPCR profiling studies

Integrated DNA Technologies will be hosting a webinar to help researchers get the most out of gene expression studies that analyze large numbers of samples.

From Integrated DNA Technologies 4 Sep 2015

Cipla enters into definitive agreements to acquire two US-based companies

Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc.

4 Sep 2015

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

A research team led by Kezhong Zhang, Ph.D., at the Wayne State University School of Medicine's Center for Molecular Medicine and Genetics, has discovered that exposure to air pollution has a direct adverse health effect on the liver and causes liver fibrosis, an illness associated with metabolic disease and liver cancer.

3 Sep 2015

Acal BFi inks channel partner agreement in Europe with SynQor

Acal BFi, European leader in advanced technology solutions, have signed a channel partner agreement in Europe with SynQor to include UK, Ireland, Denmark, Sweden, Norway, Finland, Belgium, Netherlands, Luxemburg and Italy.

3 Sep 2015

Lannett enters into definitive agreement to purchase KU for $1.23 billion

Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.

3 Sep 2015

Ascletis completes US$35 million (RMB 220 million) financing

Ascletis announced today the completion of a US$35 million (RMB 220 million) financing. The investment was led by C-Bridge Capital, joined by Tasly Pharmaceutical and Singapore-based Pavilion Capital. The valuation of the Company before financing was US$300 million.

2 Sep 2015

HeartWare International signs definitive agreement to acquire Valtech

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced today that it has entered into a definitive agreement to acquire Valtech Cardio, Ltd.

2 Sep 2015

Laccure Pessary developed for treatment and prevention of bacterial vaginosis now ready for commercialisation

The Swedish company Laccure AB has developed a breakthrough women's health product that is effective, safe and user-friendly. Laccure's owners are now aiming to divest the company to a buyer with appropriate resources to launch the product.

1 Sep 2015

AMRI, Saneca Pharmaceuticals collaborate to develop and market opium-derived APIs

AMRI and Saneca Pharmaceuticals, a.s. today announced a strategic collaboration focused on the development, manufacture and marketing of a portfolio of opium-derived active pharmaceutical ingredients, ("APIs").

31 Aug 2015

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2015 and updates on its drug development programs.

28 Aug 2015

New device turns paralysis victims' breath into words

A new device which transforms paralysis victims' breath into words - believed to be the first invention of its kind - has been developed by academics from Loughborough University.

28 Aug 2015

Sigma-Aldrich signs agreement with PHE to manufacture, supply bacterial and fungal NCTC/NCPF CRMs

Sigma-Aldrich Corporation, a leading Life Science and Technology Company, today announced it has signed an agreement with Public Health England to manufacture and supply bacterial and fungal NCTC/NCPF Certified Reference Materials (CRM) in LENTICULE disc format worldwide for use as controls in food, water, environmental and clinical testing microbiology laboratories.

27 Aug 2015

University of Nottingham to lead £6.5m research project that aims to develop next generation biomaterials

The University of Nottingham is to lead a £6.5m research project which aims to make the leap from 2D to 3D in the development of advanced materials and realise the true potential of regenerative medicine and medical devices for the future.

27 Aug 2015

Sandia researchers develop nerve-like polymer network using biological mechanisms

Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.

25 Aug 2015

Shire enters into agreement with Sanquin for CINRYZE

Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE.

25 Aug 2015

Improved ‘two-shot’ mould clear bottomed assay plates

The unique Krystal 2000 microplate range from Porvair Sciences has been optimised for luminescence and fluorescence assays.

24 Aug 2015

NYBC, UC Davis Health System partner to manufacture potential stem cell therapies

New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.

20 Aug 2015

Study shows how single-cell organisms can somersault or bend their bodies

In a paper appearing in Scientific Reports today, the motion of micro-organisms as they swim through various types of fluid channels show "quite strange and new" responses for single cell organisms, including the performance of somersaults, meandering wanderings, and even a ballistic type of behavior, wrote Sunghwan "Sunny" Jung, a member of the Virginia Tech Department of Biomedical Engineering and Mechanics.

20 Aug 2015

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS).

20 Aug 2015

NIAID exercises option to advance development of Soligenix's heat stabilized ricin toxin vaccine

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.

19 Aug 2015

Manufacturing News and Research

Further Reading

IDT to host webinar on high throughput qPCR profiling studies

Cipla enters into definitive agreements to acquire two US-based companies

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

Acal BFi inks channel partner agreement in Europe with SynQor

Lannett enters into definitive agreement to purchase KU for $1.23 billion

Ascletis completes US$35 million (RMB 220 million) financing

HeartWare International signs definitive agreement to acquire Valtech

Laccure Pessary developed for treatment and prevention of bacterial vaginosis now ready for commercialisation

AMRI, Saneca Pharmaceuticals collaborate to develop and market opium-derived APIs

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

New device turns paralysis victims' breath into words

Sigma-Aldrich signs agreement with PHE to manufacture, supply bacterial and fungal NCTC/NCPF CRMs

University of Nottingham to lead £6.5m research project that aims to develop next generation biomaterials

Sandia researchers develop nerve-like polymer network using biological mechanisms

Shire enters into agreement with Sanquin for CINRYZE

Improved ‘two-shot’ mould clear bottomed assay plates

NYBC, UC Davis Health System partner to manufacture potential stem cell therapies

Study shows how single-cell organisms can somersault or bend their bodies

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

NIAID exercises option to advance development of Soligenix's heat stabilized ricin toxin vaccine

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®